Abstract
The use of daptomycin has been associated with an elevation in creatine phosphokinase level, with a reported incidence of 2.8% in phase III clinical trials. Published case reports have documented the presence of myopathy in patients who received daptomycin; however, there have been no previously reported cases of rhabdomyolysis in animals or humans to date. We describe a case of rhabdomyolysis during therapy with daptomycin.
Cite
CITATION STYLE
Papadopoulos, S., Ball, A. M., Liewer, S. E., Martin, C. A., Winstead, P. S., & Murphy, B. S. (2006). Rhabdomyolysis during therapy with daptomycin. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America, 42(12). https://doi.org/10.1086/504379
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
